Mon, Dec 29, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

A financial transaction tax in the US, could it happen this time?

Tuesday, March 19, 2013

Bailey McCann, Opalesque New York:

The Financial Transaction Tax (FTT) is back on the table in the US. Members of congress have, steadily proposed one version of the tax or another, each year since 2009, although since congress is only focused on absolute dysfunction, the bills have yet to make it out of markup. Senator Tom Harkin (D-IA) and Congressman Peter DeFazio (D-OR), reintroduced the measure on February 28, causing editorial pages from all corners of the media universe to spring to life voicing mostly opposition to the idea. However, many of the arguments are weak, and given that financial transaction taxes are in place globally already, and set to expand in the EU, opponents may find themselves on the losing end of this battle.

Historical precedent

London has had a financial transaction tax on the books since 1694, it’s one of the oldest taxes continuously enacted in the UK, and made it to the US early on. The US levied an FTT from 1914 to 1966 on stock sales at a rate of 0.1% at issuance and 0.04% on transfers. Even now, the US still has a miniscule transaction tax - the Section 31 fee of 0.0034% on stock transactions. That fee goes to fund operating costs for the Securities and Exchange Commission (SEC).

The measure proposed by Senator Harkin and Representative DeFazio, seeks to impose a 0.03% tax on most non-consumer financial trading including stocks, bonds and other debts, except for their initial issuance. The tax would also cover all......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its